toosendanin has been researched along with tetraethylammonium in 1 studies
| Studies (toosendanin) | Trials (toosendanin) | Recent Studies (post-2010) (toosendanin) | Studies (tetraethylammonium) | Trials (tetraethylammonium) | Recent Studies (post-2010) (tetraethylammonium) |
|---|---|---|---|---|---|
| 115 | 0 | 72 | 3,877 | 10 | 298 |
| Protein | Taxonomy | toosendanin (IC50) | tetraethylammonium (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 1 | Mus musculus (house mouse) | 0.54 | |
| Solute carrier family 22 member 2 | Mus musculus (house mouse) | 3.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Q; Huang, F; Shi, Y | 1 |
1 other study(ies) available for toosendanin and tetraethylammonium
| Article | Year |
|---|---|
Inhibition of Toosendanin on the delayed rectifier potassium current in neuroblastoma x glioma NG108-15 cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 4-Aminopyridine; Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Delayed Rectifier Potassium Channels; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Glioma; Hybrid Cells; Mice; Neuroblastoma; Neuromuscular Blocking Agents; Nifedipine; Patch-Clamp Techniques; Potassium; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Rats; Tetraethylammonium; Tetraethylammonium Compounds; Verapamil | 1997 |